prenatal multivitamin
PreclinicalSmall molecule
prenatal multivitamin is one of 11 small molecule programs targeting Pregnant Women. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
10
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
11 competitors in Pregnant Women
#DrugCompanyPhaseTrials
1Vemlidy
GileadApproved
Tirosint
IInstitut Jerome Lejeune
Approved
Tdap Vaccine
SanofiPhase 3
GBS-NN/NN2
MMinervax ApS
Phase 3
Hecolin ).
IInternational Vaccine Institute
Phase 2
Nicotinamide
MMetro International Biotech, LLC
Preclinical
IV Acetaminophen
AAFT Pharmaceuticals, Ltd.
Preclinical
Choline Bitartrate
UUniversity of Minnesota
Preclinical
Antiemetic Drug
UUniversity of West Attica
Preclinical
prenatal multivitamin
DDr. Sima Hashemipour
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Pregnant Women1 trial
Vitamin D Treatment and Hypocalcemic Pregnant Women
Unknown status·—·N/A·NCT02021864·120 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for prenatal multivitamin. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- DDr. Sima Hashemipour